
Smart equipment and continuous monitoring for water network
RESEARCH PROJECTS
Advanced AI models to transform biomarker data into reproducible and scalable clinical evidence
Parkinson’s disease currently affects more than 9.4 million people worldwide. The associated rates of disability and mortality are increasing faster than those of any other neurological condition, making early diagnosis an absolute priority.
VαMPIRE — a Horizon Europe project — aims to develop an innovative in vitro diagnostic (IVD) test for the early detection of Parkinson’s disease. The solution is based on the analysis of α-synuclein (α-Syn) in neuronal-derived extracellular vesicles (NDEV), enabling detection of the disease at its earliest stages.
The project integrates advanced Artificial Intelligence models to transform biomarker data into reproducible and scalable clinical evidence.
As technology partner of the international consortium, we have already completed an initial retrospective analysis on approximately 200 patients, developing statistical tools to identify patterns related to family history and predictive accuracy.
This enables:
for Parkinson’s disease
patient management enabled by specific biomarkers
to targeted and timely treatments
of long-term disability burden
of new therapeutic strategies based on robust scientific evidence